Why the study?
Does the combination of a calcium channel blocker with an ACE inhibitor or ARB improve survival and cardiac remodeling in a rat model of hypertensive heart failure with preserved systolic function?
Population
Dahl salt-sensitive rats fed a high-salt diet from 7 weeks of age, developing hypertension and heart failure…
Comparison
Azelnidipine, temocapril, olmesartan, and their… vs Monotherapy
Design
Preclinical
Authors
Loading...
May support CCB-ACEI combinations in hypertensive HFpEF rat models; leaves open translation to clinical practice.
Does the combination of a calcium channel blocker with an ACE inhibitor or ARB improve survival and cardiac remodeling in a rat model of hypertensive heart failure with preserved systolic function?
The combination of a calcium channel blocker with an ARB or ACE inhibitor provides additive benefits on survival and cardiac fibrosis in a hypertensive rat model of heart failure with preserved systolic function.
Kim‐Mitsuyama et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: